Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Source: Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends
Watch this on-demand webcast capturing a live CCO webinar at AACR 2021 to gain expert perspectives on the latest data informing precision medicine for non-small-cell lung cancer, including standard-of-care biomarkers for targeted and immune checkpoint inhibitor–based therapies and those that promise to affect management strategies for patients in the near future.
Nathan Pennell, MD, PhD
Program Director
Jamie E. Chaft, MD
Stephen Liu, MD
Released: May 18, 2021 Expiration: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Lilly
Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings